| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acute myeloid leukemia in patients previously diagnosed with breast cancer: Experience of the GIMEMA group
|
Pagano, L.
|
|
|
12 |
2 |
p. 203-208
|
artikel
|
| 2 |
Acute myeloid leukemia in patients previously diagnosed with breastcancer: Experience of the GIMEMA group
|
L. Pagano
|
|
2001
|
12 |
2 |
p. 203-207
5 p.
|
artikel
|
| 3 |
Book review
|
Tondini, C.
|
|
|
12 |
2 |
p. 144
|
artikel
|
| 4 |
Cancer information under threat: The case for legislation
|
Brewster, D.H.
|
|
|
12 |
2 |
p. 145-147
|
artikel
|
| 5 |
Cancer information under threat: The case for legislation
|
D. H. Brewster
|
|
2001
|
12 |
2 |
p. 147-149
3 p.
|
artikel
|
| 6 |
CEA and CA19-9 measurement as a monitoring parameter in metastatic colorectal cancer (CRC) under palliative first-line chemotherapy with weekly 24-hour infusion of high-dose 5-fluorouracil (5-FU) and folinic acid (FA)
|
Hanke, B.
|
|
|
12 |
2 |
p. 221-226
|
artikel
|
| 7 |
CEA and CA 19-9 measurement as a monitoring parameter in metastaticcolorectal cancer (CRC) under palliative first-line chemotherapy with weekly24-hour infusion of high-dose 5-fluorouracil (5-FU) and folinic acid(FA)
|
B. Hanke
|
|
2001
|
12 |
2 |
p. 221-226
6 p.
|
artikel
|
| 8 |
Combination chemotherapy for colon cancer: De gustibus non est disputandum
|
Haller, D.G.
|
|
|
12 |
2 |
p. 278
|
artikel
|
| 9 |
Complete response of an HIV negative gastric Kaposi’s sarcoma (KS) patient with peritoneal carcinomatosis by liposomal daunorubicin treatment
|
Fléchon, A.
|
|
|
12 |
2 |
p. 275-276
|
artikel
|
| 10 |
Complete response of an HIV negative gastric Kaposi's sarcoma (KS)patientwith peritoneal carcinomatosis by liposomal daunorubicin treatment
|
A. Fléchon
|
|
2001
|
12 |
2 |
p. 275-276
2 p.
|
artikel
|
| 11 |
Contents of next issue
|
|
|
|
12 |
2 |
p. v
|
artikel
|
| 12 |
Copyright
|
|
|
|
12 |
2 |
p. iii
|
artikel
|
| 13 |
Dietary glycemic load and colorectal cancer risk
|
Franceschi, S.
|
|
|
12 |
2 |
p. 173-178
|
artikel
|
| 14 |
Dietary glycemic load and colorectal cancer risk
|
S. Franceschi
|
|
2001
|
12 |
2 |
p. 173-178
6 p.
|
artikel
|
| 15 |
Docetaxel and cisplatin in locally advanced or metastatic squamous-cell carcinoma of the head and neck: A phase II study of the Southern Italy Cooperative Oncology Group (SICOG)
|
Caponigro, F.
|
|
|
12 |
2 |
p. 199-202
|
artikel
|
| 16 |
Docetaxel and cisplatin in locally advanced or metastatic squamous-cellcarcinoma of the head and neck: A phase II study of the Southern ItalyCooperative Oncology Group (SICOG)
|
F. Caponigro
|
|
2001
|
12 |
2 |
p. 199-202
4 p.
|
artikel
|
| 17 |
Editorial board
|
|
|
|
12 |
2 |
p. iv
|
artikel
|
| 18 |
5-Fluorouracil induced Fas upregulation associated with apoptosis in liver metastases of colorectal cancer patients
|
Backus, H.H.J.
|
|
|
12 |
2 |
p. 209-216
|
artikel
|
| 19 |
5-Fluorouracil induced Fas upregulation associated with apoptosis inliver metastases of colorectal cancer patients
|
H. H. J. Backus
|
|
2001
|
12 |
2 |
p. 209-216
8 p.
|
artikel
|
| 20 |
Hepatocellular carcinoma
|
Hussain, S.A.
|
|
|
12 |
2 |
p. 161-172
|
artikel
|
| 21 |
Hepatocellular carcinoma
|
S. A. Hussain
|
|
2001
|
12 |
2 |
p. 161-172
12 p.
|
artikel
|
| 22 |
In this Issue
|
|
|
|
12 |
2 |
p. v
|
artikel
|
| 23 |
J. M. Debois, Selected Topics in Oncology. An In-Depth Study of18 Cancers Usually Neglected in Classical Textbooks
|
C. Tondini
|
|
2001
|
12 |
2 |
p. 144-144
1 p.
|
artikel
|
| 24 |
Medical oncology in Europe: More efforts needed
|
|
|
|
12 |
2 |
p. 139-140
|
artikel
|
| 25 |
Microsatellite instability: Application in hereditary non-polyposis colorectal cancer
|
Saletti, P.
|
|
|
12 |
2 |
p. 151-160
|
artikel
|
| 26 |
Microsatellite instability: Application in hereditary non-polyposiscolorectal cancer
|
P. Saletti
|
|
2001
|
12 |
2 |
p. 151-160
10 p.
|
artikel
|
| 27 |
Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse
|
Brada, M.
|
|
|
12 |
2 |
p. 259-266
|
artikel
|
| 28 |
Multicenter phase II trial of temozolomide in patients with glioblastomamultiforme at first relapse
|
M. Brada
|
|
2001
|
12 |
2 |
p. 259-266
8 p.
|
artikel
|
| 29 |
Murder
|
|
|
|
12 |
2 |
p. 141
|
artikel
|
| 30 |
Myeloid metaplasia of the breast
|
Cufer, T.
|
|
|
12 |
2 |
p. 267-270
|
artikel
|
| 31 |
Myeloid metaplasia of the breast
|
T. Cufer
|
|
2001
|
12 |
2 |
p. 267-270
4 p.
|
artikel
|
| 32 |
Neuro-oncology clinical trials: Promise and pitfalls
|
Gilbert, M.R.
|
|
|
12 |
2 |
p. 149-150
|
artikel
|
| 33 |
Neuro-oncology clinical trials: Promise and pitfalls
|
M. R. Gilbert
|
|
2001
|
12 |
2 |
p. 145-146
2 p.
|
artikel
|
| 34 |
Nitroso-urea–cisplatin-based chemotherapy associated with valproate: Increase of haematologic toxicity
|
Bourg, V.
|
|
|
12 |
2 |
p. 217-220
|
artikel
|
| 35 |
Nitroso-ureacisplatin-based chemotherapy associated withvalproate:Increase of haematologic toxicity
|
V. Bourg
|
|
2001
|
12 |
2 |
p. 217-219
3 p.
|
artikel
|
| 36 |
Nokia, Ericsson and others are happier …
|
|
|
|
12 |
2 |
p. 140-141
|
artikel
|
| 37 |
Octreotide in the treatment of severe chemotherapy-induced diarrhea
|
Zidan, J.
|
|
|
12 |
2 |
p. 227-230
|
artikel
|
| 38 |
Octreotide in the treatment of severe chemotherapy-induced diarrhea
|
J. Zidan
|
|
2001
|
12 |
2 |
p. 227-229
3 p.
|
artikel
|
| 39 |
Paclitaxel in combination with carboplatin as salvage treatment in refractory small-cell lung cancer (SCLC): A multicenter phase II study
|
Kakolyris, S.
|
|
|
12 |
2 |
p. 193-198
|
artikel
|
| 40 |
Paclitaxel in combination with carboplatin as salvage treatment inrefractory small-cell lung cancer (SCLC): A multicenter phase II study
|
S. Kakolyris
|
|
2001
|
12 |
2 |
p. 193-197
5 p.
|
artikel
|
| 41 |
Perhaps not everyone knows that…
|
|
|
|
12 |
2 |
p. 141-143
|
artikel
|
| 42 |
Phase II study of temozolomide in heavily pretreated cancer patients with brain metastases
|
Christodoulou, C.
|
|
|
12 |
2 |
p. 249-254
|
artikel
|
| 43 |
Phase II study of temozolomide in heavily pretreated cancer patients withbrain metastases
|
C. Christodoulou
|
|
2001
|
12 |
2 |
p. 249-254
6 p.
|
artikel
|
| 44 |
Phase II trial of two-weekly gemcitabine in patients with advanced biliary tract cancer
|
Penz, M.
|
|
|
12 |
2 |
p. 183-186
|
artikel
|
| 45 |
Phase II trial of two-weekly gemcitabine in patients with advancedbiliary tract cancer
|
M. Penz
|
|
2001
|
12 |
2 |
p. 183-186
4 p.
|
artikel
|
| 46 |
Pre-clinical and clinical study of QC12, a water-soluble, pro-drug of quercetin
|
Mulholland, P.J.
|
|
|
12 |
2 |
p. 245-248
|
artikel
|
| 47 |
Pre-clinical and clinical study of QC12, a water-soluble, pro-drug ofquercetin
|
P. J. Mulholland
|
|
2001
|
12 |
2 |
p. 245-248
4 p.
|
artikel
|
| 48 |
Representation on International Scientific Committees
|
Abratt, R.P.
|
|
|
12 |
2 |
p. 277-278
|
artikel
|
| 49 |
Representation on International Scientific Committees
|
R. P. Abratt
|
|
2001
|
12 |
2 |
p. 277-278
2 p.
|
artikel
|
| 50 |
Response to chemotherapy is a major parameter-influencing long-term survival of metastatic breast cancer patients
|
Pierga, J.Y.
|
|
|
12 |
2 |
p. 231-238
|
artikel
|
| 51 |
Response to chemotherapy is a major parameter-influencing long-termsurvival of metastatic breast cancer patients
|
J. Y. Pierga
|
|
2001
|
12 |
2 |
p. 231-237
7 p.
|
artikel
|
| 52 |
Restructuring English oncology: Will it improve participation in clinical trials and cancer patient care?
|
|
|
|
12 |
2 |
p. 139
|
artikel
|
| 53 |
Restructuring English oncology: Will it improve participation inclinical trials and cancer patient care?; Medical oncology in Europe:More efforts needed; Youve come a long way, baby;Nokia, Ericsson and others are happier...; Murder; Perhaps not everyone knowsthat...
|
|
|
2001
|
12 |
2 |
p. 139-144
6 p.
|
artikel
|
| 54 |
Severe prognosis of signet-ring cell adenocarcinoma occurring in Meckel’s diverticulum
|
Lippe, P.
|
|
|
12 |
2 |
p. 277
|
artikel
|
| 55 |
Severe prognosis of signet-ring cell adenocarcinoma occurring inMeckels diverticulum
|
P. Lippe
|
|
2001
|
12 |
2 |
p. 277-277
1 p.
|
artikel
|
| 56 |
Single-agent oxaliplatin in pretreated advanced breast cancer patients: A phase II study
|
Garufi, C.
|
|
|
12 |
2 |
p. 179-182
|
artikel
|
| 57 |
Single-agent oxaliplatin in pretreated advanced breast cancer patients:A phase II study
|
C. Garufi
|
|
2001
|
12 |
2 |
p. 179-182
4 p.
|
artikel
|
| 58 |
Sustained response of sarcomatoid renal-cell carcinoma to MAID chemotherapy: Case report and review of the literature
|
Bangalore, N.
|
|
|
12 |
2 |
p. 271-274
|
artikel
|
| 59 |
Sustained response of sarcomatoid renal-cell carcinoma to MAIDchemotherapy: Case report and review of the literature
|
N. Bangalore
|
|
2001
|
12 |
2 |
p. 271-274
4 p.
|
artikel
|
| 60 |
Table of Contents
|
|
|
|
12 |
2 |
p. ii-iii
|
artikel
|
| 61 |
Temozolomide as a second-line systemic regimen in recurrent high-grade glioma: A phase II study
|
Brandes, A.A.
|
|
|
12 |
2 |
p. 255-258
|
artikel
|
| 62 |
Temozolomide as a second-line systemic regimen in recurrenthigh-grade glioma: A phase II study
|
A. A. Brandes
|
|
2001
|
12 |
2 |
p. 255-257
3 p.
|
artikel
|
| 63 |
Use of the ratio of time to progression following first- and second-line therapy to document the activity of the combination of oxaliplatin with 5-fluorouracil in the treatment of colorectal carcinoma
|
Bonetti, A.
|
|
|
12 |
2 |
p. 187-192
|
artikel
|
| 64 |
Use of the ratio of time to progression following first- and second-linetherapy to document the activity of the combination of oxaliplatin with5-fluorouracil in the treatment of colorectal carcinoma
|
A. Bonetti
|
|
2001
|
12 |
2 |
p. 187-191
5 p.
|
artikel
|
| 65 |
Vascular endothelial growth factor expression, S-phase fraction and thymidylate synthase quantitation in node-positive colon cancer: Relationships with tumor recurrence and resistance to adjuvant chemotherapy
|
Cascinu, S.
|
|
|
12 |
2 |
p. 239-244
|
artikel
|
| 66 |
Vascular endothelial growth factor expression, S-phase fraction andthymidylate synthase quantitation in node-positive colon cancer: Relationshipswith tumor recurrence and resistance to adjuvant chemotherapy
|
S. Cascinu
|
|
2001
|
12 |
2 |
p. 239-244
6 p.
|
artikel
|
| 67 |
“You’ve come a long way, baby”
|
|
|
|
12 |
2 |
p. 140
|
artikel
|
Tijdschrift beschrijving